πŸ‡ΊπŸ‡Έ FDA
Patent

US 8211635

P53 modulator and cancer target

granted A61KA61K31/7105A61P

Quick answer

US patent 8211635 (P53 modulator and cancer target) held by The Board of Regents of the University of Texas System expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/7105, A61P, A61P35/00, A61P35/02